Daly

Daly v. Boehringer Ingelheim Pharmaceuticals, Inc.

Good Law
United States District Court, Eastern District of CaliforniaApril 8, 20212:21-cv-00530California397 words

Opinion

Trial Court Opinion

UNITED STATES JUDICIAL PANEL FILED

on MULTIDISTRICT LITIGATION oe Nr 08 2021

IN RE: ZANTAC (RANITIDINE) PRODUCTS

LIABILITY LITIGATION MDL No. 2924

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO —59)

On February 6, 2020, the Panel transferred 12 civil action(s) to the United States District Court for the Southern District of Florida for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. See 437 F.Supp.3d 1368 (J.P.M.L. 2020). Since that time, 310 additional action(s) have been transferred to the Southern District of Florida. With the consent of that court, all such actions have been assigned to the Honorable Robin L. Rosenberg. It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the Southern District of Florida and assigned to Judge Rosenberg. Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the Southern District of Florida for the…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.